Overview

Ocular Changes With Alpha-2 Receptor Agonist.

Status:
Recruiting
Trial end date:
2023-09-22
Target enrollment:
Participant gender:
Summary
selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.
Phase:
N/A
Details
Lead Sponsor:
Benha University
Treatments:
Ophthalmic Solutions